Biomed & Biotech Firms - Publicly Traded*

Quidel Corp.

Company Website

10165 McKellar Ct.
San Diego, CA 92121

Company Est.:

Sourcebook Data

View all the companies in Biomed & Biotech Firms - Publicly Traded*

Quidel Corp.

Market Cap as of 6/12/2015

$793,343,872

Market Cap as of 7/03/2014

$757,286,763

Market Cap as of 07/02/2013

$886,116,455

Market Cap as of 06/26/2012

$500,928,864

Market Cap as of 01/04/2012

$511,041,700

Market Cap as of 06/20/2011

$497,483,600

Market Cap as of 01/06/2011

$430,220,400

Exchange and Ticker Symbol

Nasdaq: QDEL

Fields of Research

Develops, manufactures and markets diagnostic testing solutions for applications in infectious diseases, women’s health and gastrointestinal diseases

Major Products

QuickVue influenza test;
QuickVue Strep A tests;
QuickVue RSV test;
ELVIS HSV system;
QuickVue and RapidVue pregnancy tests;
Thyretain;
QuickVue Chlamydia test;
clinical and research products for the assessment of osteoporosis and the evaluation of bone resorption/formation;
fecal immunochemical test; indirect fluorescent antibody products; Helicobacter pylori tests

Executives

Randall Steward

  • Chief Financial Officer

Douglas Bryant

  • Chief Executive Officer
  • President